Results 201 to 210 of about 78,835 (252)

The associations of systemic inflammation and insulin resistance-related indicators with psychopathology and BDNF in patients with chronic schizophrenia. [PDF]

Front Psychiatry
Tian Y, Zhuang Y, Sun L, Xue J, Tang P, Zhang Y, Liu L, Yao X, Li W, Xia L, Liu H.   +10 more
europepmc   +1 more source

EEG findings in SERAC1‐related MEGD(H)EL syndrome

Epileptic Disorders, EarlyView.
Apurva Patel, Dalila Lewis, Thomas Koch
wiley   +1 more source

Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly. [PDF]

Diabetes Care
Ganeshalingam AA, Uhrenholt N, Arnfred S, Gæde P, Pedersen AK, Bilenberg N, Frystyk J.   +6 more
europepmc   +1 more source

Analysis of the prevalence of dyslipidemia in early-onset schizophrenia patients and its correlation with clinical characteristics. [PDF]

Front Psychiatry
Li K, Liu Z, Sun L, Zhang J, Yin X, Zhang Z, Cao C.   +6 more
europepmc   +1 more source

Nutritional psychiatry on the move: the activities of the ECNP Nutrition Network to leverage nutrition for brain health. [PDF]

World Psychiatry
Cirulli F, Dickson SL.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Metabolic Syndrome in Child and Adolescent Psychiatry

Psychiatric Annals, 2020
In adults, metabolic syndrome (MetS) is defined as a constellation of at least 3 of 5 cardiometabolic risk factors: central obesity, hyperglycemia, elevated blood pressure, elevated triglycerides, and decreased high-density lipoprotein cholesterol.
Zheala Qayyum, Hun Millard, Hyun Jung Kim   +2 more
exaly   +2 more sources

Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study

European Archives of Psychiatry and Clinical Neuroscience, 2019
The information on prevalence of obesity, diabetes, metabolic syndrome (MetS) and cardiovascular risk (CVR) and on sociodemographic variables available in patients with psychiatric diseases about to be treated with weight gain-associated medication (e.g., clozapine, mirtazapine, quetiapine) is limited.
Richard Musil, Barbara Bianca Barton, Musil Richard   +2 more
exaly   +3 more sources

Metabolic psychiatry gains momentum with new research grants

Mental Health Weekly
The rapidly advancing field of metabolic psychiatry — exploring the links between metabolism and mental health — just received a major boost. Six early‐career scientists and clinicians have been selected for the inaugural Metabolic Psychiatry Scholar Award, a program designed to deepen understanding of how metabolic processes influence psychiatric ...
exaly   +2 more sources

Responsible prescription in Psychiatry: Metabolic Syndrome, an unresolved issue?

Revista Colombiana De Psiquiatría (English Ed ), 2021
Carolina Marley Suárez Benites
exaly   +4 more sources